Physician profile
William C Mitchell
NPI 1689672271
$6,180.25
in general payments reported to CMS, 2019-2025
52 companies · $710 in 2025
The $710 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $970 · 2020: $550 · 2021: $623 · 2022: $971 · 2023: $1,267 · 2024: $1,090 · 2025: $710.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,976 · Education: $90.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,976.43 |
| Education | $90.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agiliti Surgical, INC. | $833.30 | 2023-2025 | Koelis Trinity Fusion Biopsy System, Sonablate Hifu, Cyberblade |
| Boston Scientific Corporation | $587.30 | 2019-2025 | General - Female Sui |
| Pfizer INC. | $511.82 | 2019-2024 | |
| Astellas Pharma US INC | $491.08 | 2019-2024 | Myrbetriq |
| Abbvie INC. | $345.24 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $283.52 | 2019-2023 | Xiaflex, Aveed |
| Antares Pharma, INC. | $263.70 | 2019-2023 | Xyosted, Tlando, Nocdurna |
| Myriad Genetic Laboratories, INC. | $203.32 | 2023 | Prolaris |
| Janssen Biotech, INC. | $178.33 | 2022-2025 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $154.81 | 2023-2025 | Gemtesa |
| Axonics, INC. | $146.32 | 2022-2024 | Axonics, Bulkamid |
| Accord Healthcare, INC. | $139.31 | 2022-2025 | |
| Teleflex LLC | $138.73 | 2022-2025 | Urolift |
| Tolmar Pharmaceuticals, INC. | $134.05 | 2019-2021 | |
| Procept Biorobotics Corporation | $124.64 | 2022-2025 | Aquabeam System |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.